CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0001 (-33.33%)
Apr 15, 2026, 1:42 PM EST
CNBX Pharmaceuticals Market Cap
CNBX Pharmaceuticals has a market cap or net worth of $183.87 thousand as of April 15, 2026. Its market cap has decreased by -40.85% in one year.
Market Cap
183.87K
Enterprise Value
1.34M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 20, 2011, CNBX Pharmaceuticals's market cap has decreased from 238.06K to 183.87K, a decrease of -22.76%. That is a compound annual growth rate of -1.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 183.87K | -38.97% |
| Dec 31, 2025 | 301.28K | 30.86% |
| Dec 31, 2024 | 230.22K | -47.89% |
| Dec 29, 2023 | 441.78K | -81.12% |
| Dec 30, 2022 | 2.34M | -79.95% |
| Dec 31, 2021 | 11.67M | -58.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actavia Life Sciences | 385.91K |
| THC Farmaceuticals | 380.76K |
| Regenerative Medical Technology Group | 328.47K |
| Altamira Therapeutics | 286.35K |
| Abpro Holdings | 282.49K |
| Helix BioMedix | 224.71K |
| Regen BioPharma | 210.86K |
| Ampio Pharmaceuticals | 173.20K |